SunilHAbhyankarMD

Professor, Internal Medicine, Division of Hematological Malignancy and Cellular therapy, University Kansas School of Medicine

Join to view full profile

Dr. Abhyankar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Abhyankar's full profile

Already have an account?

Office
2330 Shawnee Mission Pkwy
Stop 5003
Westwood, KS 66205
Phone+1 913-588-6030

Fax+1 913-588-4085

Education & Training

SUNY Downstate Health Sciences UniversityFellowship, Pediatric Hematology/Oncology, 1987 - 1989
Seth G.S. Medical CollegeClass of 1981

Certifications & Licensure

KS State Medical License 2002 - 2025
MO State Medical License 2000 - 2025
SC State Medical License 1994 - 2021
KY State Medical License 1992 - 2001
NY State Medical License 1999 - 2001
WI State Medical License 1989 - 1991
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Peripheral Blood Stem Cell (PBSC) Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine Start of enrollment: 2010 Jan 01
Completed
Early Phase 1
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
Completed
Phase 2, Phase 3
A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma Start of enrollment: 2010 Sep 01
Completed
Early Phase 1
Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy. Start of enrollment: 2010 Aug 01
Completed
Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease Start of enrollment: 2010 Jun 01
Completed
Early Phase 1
Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901) Start of enrollment: 2011 Jun 01
Terminated
Phase 3
Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL Start of enrollment: 2012 Nov 01
Completed
Phase 3
Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE) Start of enrollment: 2014 Aug 29
Terminated
Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) Start of enrollment: 2014 Aug 01
Completed
Phase 2
Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML Start of enrollment: 2018 Aug 15
Recruiting
Phase 3
Roles: Contact
DALY II USA/ MB-CART2019.1 for DLBCL Start of enrollment: 2021 May 25
Recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

129 citations
Belumosudil for Chronic Graft-versus-Host Disease (cGVHD) After 2 or More Prior Lines of Therapy: The ROCKstar Study
Corey Cutler, Stephanie J. Lee, Sally Arai, Marcello Rotta, Behyar Zoghi
Blood. 2020-11-05
8 citations
Bronchoscopic features, associations, and outcomes of organizing pneumonia following allogeneic hematopoietic stem cell transplantation.
Kyle R. Brownback, John W Frey, Sunil Abhyankar
Annals of Hematology. 2019-07-04
6 citations
Human Wharton's Jelly-derived mesenchymal stem cells prevent acetaminophen-induced liver injury in a mouse model unlike human dermal fibroblasts.
David S Umbaugh, Rupal P Soder, Nga T Nguyen, Olamide Adelusi, Dakota R Robarts
Archives of Toxicology. 2022-12-01

Journal Articles

A Phase II/III Randomized, Multicenter Trial of Prednisone /Sirolimus vs Prednisone/Sirolimus/Calcineurin Inhibitor for Treatment of Chronic Graft-Versus-Host Disease:...
Amin M Alousi, Mukta Arora, Luciano J Costa, Aleksandr Lazaryan, Daniel J Weisdorf, Sunil Abhyankar, Eneida R Nemecek, Haematologica

Press Mentions

Cancer Center Is a Contributor to 49 Research Studies at the 62nd American Society of Hematology Annual MeetingDecember 4th, 2020
Overland Park Bone Marrow Transplant Recipient Meets Donor in New YorkFebruary 21st, 2020
Optimizing the Immune System to Beat CancerJune 1st, 2023